R. Sinha, Rahul Rahul R
{"title":"Post Liver Transplantation Diarrhea: Etiology, Evaluation and Treatment","authors":"R. Sinha, Rahul Rahul R","doi":"10.5530/ijmedph.2021.3.23","DOIUrl":null,"url":null,"abstract":"Copyright © 2021 Phcog.Net. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license. Cite this article : Sinha R, Rahul. Post Liver Transplantation Diarrhea: Etiology, Evaluation and Treatment. Int J Med Public Health. 2021;11(3):126-32. ABSTRACT Diarrhea is a frequent post-operative complication following liver transplantation. It occurs frequently in the initial 3-4 months. Common etiologic factors include immunosuppressive drugs (Mycophenolate mofetil, Tacrolimus and Cyclosporine) and infection (Clostridium difficile, Cytomegalovirus and Rotavirus infection). Inflammatory bowel disease, malignancy and graft versus host disease are infrequent but important causes. Actual incidence of Diarrhea among liver transplant recipients remains elusive as it is often under-reported. However, as per the current literature, it occurs in 10-40 percent of recipients. It can result in dehydration, dyselectrolytemia, derangement of renal profile and even graft loss. The alteration in immunosuppressive drugs in early post-operative period may predispose graft rejection. High index of suspicion and systematic evaluation is pertinent for timely diagnosis. The review summarizes the important causes, epidemiology, recent updates, evaluation and management of the of post liver transplant diarrhea.","PeriodicalId":90863,"journal":{"name":"International journal of medicine and public health","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of medicine and public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/ijmedph.2021.3.23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
肝移植后腹泻:病因、评价和治疗
版权所有©2012phcog.net这是一篇基于知识共享署名4.0国际许可协议的开放获取文章。引用本文:Sinha R, Rahul。肝移植后腹泻:病因、评价和治疗。国际医学与公共卫生杂志。2021;11(3):126-32。腹泻是肝移植术后常见的并发症。它经常发生在最初的3-4个月。常见的病因包括免疫抑制药物(霉酚酸酯、他克莫司和环孢素)和感染(艰难梭菌、巨细胞病毒和轮状病毒感染)。炎症性肠病、恶性肿瘤和移植物抗宿主病是罕见但重要的病因。肝移植受者中腹泻的实际发生率仍然难以捉摸,因为它经常被低估。然而,根据目前的文献,它发生在10- 40%的接受者身上。它可导致脱水、电解质障碍、肾脏轮廓紊乱,甚至移植物丢失。术后早期免疫抑制药物的改变可能诱发移植排斥反应。高怀疑指数和系统评价有助于及时诊断。本文综述了肝移植后腹泻的主要原因、流行病学、最新进展、评价和处理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。